Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study

被引:388
作者
El-Salhy, Magdy [1 ,2 ]
Hatlebakk, Jan Gunnar [2 ]
Gilja, Odd Helge [2 ]
Kristoffersen, Anja Brathen [3 ]
Hausken, Trygve [2 ]
机构
[1] Stord Hosp, Stord, Norway
[2] Univ Bergen, Dept Clin Med, Fac Med & Dent, Bergen, Norway
[3] Genet Anal AS, Oslo, Norway
关键词
QUALITY-OF-LIFE; CLOSTRIDIUM-DIFFICILE INFECTION; GUT MICROBIOTA; IBS; ANTIBIOTICS; DYSBIOSIS; SEVERITY; SMOKING; DIET;
D O I
10.1136/gutjnl-2019-319630
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective Faecal microbiota transplantation (FMT) from healthy donors to patients with irritable bowel syndrome (IBS) has been attempted in two previous double-blind, placebo-controlled studies. While one of those studies found improvement of the IBS symptoms, the other found no effect. The present study was conducted to clarify these contradictory findings. Design This randomised, double-blind, placebo-controlled study randomised 165 patients with IBS to placebo (own faeces), 30 g FMT or 60 g FMT at a ratio of 1:1:1. The material for FMT was obtained from one healthy, well-characterised donor, frozen and administered via gastroscope. The primary outcome was a reduction in the IBS symptoms at 3 months after FMT (response). A response was defined as a decrease of 50 or more points in the total IBS symptom score. The secondary outcome was a reduction in the dysbiosis index (DI) and a change in the intestinal bacterial profile, analysed by 16S rRNA gene sequencing, at 1 month following FMT. Results Responses occurred in 23.6%, 76.9% (p<0.0001) and 89.1% (p<00.0001) of the patients who received placebo, 30 g FMT and 60 g FMT, respectively. These were accompanied by significant improvements in fatigue and the quality of life in patients who received FMT. The intestinal bacterial profiles changed also significantly in the groups received FMT. The FMT adverse events were mild self-limiting gastrointestinal symptoms. Conclusions FMT is an effective treatment for patients with IBS. Utilising a well-defined donor with a normal DI and favourable specific microbial signature is essential for successful FMT. The response to FMT increases with the dose. Trial registration www.clinicaltrials.gov (NCT03822299) and www.cristin.no (ID657402).
引用
收藏
页码:859 / 867
页数:9
相关论文
共 43 条
[1]  
Agency EM, 2014, GUID EV MED PROD TRE
[2]   Quality of life in patients with subjective food hypersensitivity: Applicability of the 10-item short form of the Nepean Dyspepsia Index [J].
Arslan, G ;
Lind, R ;
Olafsson, S ;
Florvaag, E ;
Berstad, A .
DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (04) :680-687
[3]   Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs [J].
Bennet, Sean M. P. ;
Bohn, Lena ;
Storsrud, Stine ;
Liljebo, Therese ;
Collin, Lena ;
Lindfors, Perjohan ;
Tornblom, Hans ;
Ohman, Lena ;
Simren, Magnus .
GUT, 2018, 67 (05) :872-881
[4]   Smoking Cessation Alters Intestinal Microbiota: Insights from Quantitative Investigations on Human Fecal Samples Using FISH [J].
Biedermann, Luc ;
Bruelisauer, Karin ;
Zeitz, Jonas ;
Frei, Pascal ;
Scharl, Michael ;
Vavricka, Stephan R. ;
Fried, Michael ;
Loessner, Martin J. ;
Rogler, Gerhard ;
Schuppler, Markus .
INFLAMMATORY BOWEL DISEASES, 2014, 20 (09) :1496-1501
[5]  
Brandt LJ, 2015, AM J GASTROENTEROL, V110, P18, DOI [10.1038/ajg.2014.295, 10.1038/ajg.2014.395]
[6]  
Bull Matthew J, 2015, Integr Med (Encinitas), V14, P25
[7]   European consensus conference on faecal microbiota transplantation in clinical practice [J].
Cammarota, Giovanni ;
Ianiro, Gianluca ;
Tilg, Herbert ;
Rajilic-Stojanovic, Mirjana ;
Kump, Patrizia ;
Satokari, Reetta ;
Sokol, Harry ;
Arkkila, Perttu ;
Pintus, Cristina ;
Hart, Ailsa ;
Segal, Jonathan ;
Aloi, Marina ;
Masucci, Luca ;
Molinaro, Antonio ;
Scaldaferri, Franco ;
Gasbarrini, Giovanni ;
Lopez-Sanroman, Antonio ;
Link, Alexander ;
De Groot, Pieter ;
de Vos, Willem M. ;
Hoegenauer, Christoph ;
Malfertheiner, Peter ;
Mattila, Eero ;
Milosavljevic, Tomica ;
Nieuwdorp, Max ;
Sanguinetti, Maurizio ;
Simren, Magnus ;
Gasbarrini, Antonio .
GUT, 2017, 66 (04) :569-580
[8]   The interaction between smoking, alcohol and the gut microbiome [J].
Capurso, Gabriele ;
Lahner, Edith .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2017, 31 (05) :579-588
[9]   Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD [J].
Casen, C. ;
Vebo, H. C. ;
Sekelja, M. ;
Hegge, F. T. ;
Karlsson, M. K. ;
Ciemniejewska, E. ;
Dzankovic, S. ;
Froyland, C. ;
Nestestog, R. ;
Engstrand, L. ;
Munkholm, P. ;
Nielsen, O. H. ;
Rogler, G. ;
Simren, M. ;
Ohman, L. ;
Vatn, M. H. ;
Rudi, K. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (01) :71-83
[10]   Factors Affecting Gastrointestinal Microbiome Development in Neonates [J].
Chong, Clara Yieh Lin ;
Bloomfield, Frank H. ;
O'Sullivan, Justin M. .
NUTRIENTS, 2018, 10 (03)